HyperCharge Health adds Genesis Regenerative protein array to clinic care

HyperCharge Health in Edina, Minnesota, has begun using Genesis Regenerative’s Regenerative Protein Array alongside a new book and podcast from founder Dr. Stefano Sinicropi. The move extends the clinic’s longevity-focused model with a non-cellular therapy the practice says can fit into fast, outpatient care plans.

Why it matters: - HyperCharge Health is positioning itself around longevity care and non-surgical treatment options that aim to go beyond standard primary care. - The clinic’s use of Genesis Regenerative’s Regenerative Protein Array adds a non-cellular option to its patient care mix. - Dr. Stefano Sinicropi is pairing the clinical rollout with a book and podcast that reinforce the clinic’s healthspan-focused message.

What happened: - HyperCharge Health announced the clinical integration of Genesis Regenerative’s Regenerative Protein Array, or RPA. - The rollout coincides with the release of Dr. Stefano Sinicropi’s book, Wellness at the Speed of Light: Shatter the Shackles of a Broken System and Become the CEO of Your Own Health, and a matching podcast series. - The clinic is based at 7450 France Avenue South in Edina, Minnesota.

The details: - Dr. Sinicropi is the founder of HyperCharge Health and a board-certified orthopedic spine surgeon trained at Columbia University. - He has performed more than 10,000 spinal surgeries and evaluated more than 25,000 patients over a 20-year career. - He has given TEDx talks in Minneapolis and at Harvard Square on light and laser therapies. - HyperCharge Health says the RPA is an advanced non-DNA signaling technology. - The clinic says the RPA is a highly concentrated, acellular matrix with more than 300 verifiable proteins, cytokines and signaling molecules. - HyperCharge Health says the product is reconstituted directly in the vial on an outpatient basis. - The clinic says the acellular profile contains no live cellular matter or donor DNA. - HyperCharge Health says that design eliminates the risks associated with cellular transfer. - The clinic says the process allows a 10-minute application and can reduce recovery time for traveling patients. - Dr. Sinicropi said the clinic was created because traditional medicine did not offer enough options and too often ties treatment choices to insurance coverage. - Dr. Sinicropi also said the RPA is easy to administer for out-of-state patients because it can be reconstituted in the vial. - Care pathways at HyperCharge Health may also include advanced medical diagnostics, hormone optimization, customized peptide therapies, IV vitamin therapy and targeted neural recovery protocols. - The clinic says it conducts remote case reviews before a patient arrives to support a concierge-style experience. - HyperCharge Health’s website is More information. - The book is available on Amazon. - The podcast is on Spotify. - Genesis Regenerative’s website is More information.

Between the lines: - The announcement blends product adoption with personal branding, using the book and podcast to frame the clinic’s philosophy around patient ownership and healthspan. - The messaging suggests HyperCharge Health wants to differentiate itself from conventional care by emphasizing outpatient convenience, non-cellular therapies and individualized protocols. - The pitch leans heavily on performance, longevity and systems-level care rather than traditional symptom management.

What’s next: - HyperCharge Health is likely to continue building around its integrative model as it promotes the new book, podcast and RPA-based care pathways. - The clinic says prospective patients can begin with remote review before traveling to Edina for treatment. - Genesis Regenerative is continuing to market RPA as part of a broader push to set a new standard of care for non-cellular products.

The bottom line: - HyperCharge Health is using a new protein-array therapy and a book launch to sharpen its identity as a longevity clinic built around fast, integrative, non-surgical care.